Figure 4.
Time to occurrence of radiodermatitis in breast cancer patients treated with CLC and in a historical control group. Adapted from Stefanelli.50
Time to occurrence of radiodermatitis in breast cancer patients treated with CLC and in a historical control group. Adapted from Stefanelli.50